{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:07Z","timestamp":1786982107945,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,7,19]],"date-time":"2015-07-19T00:00:00Z","timestamp":1437264000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s11864-015-0361-5","type":"journal-article","created":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T22:16:25Z","timestamp":1437171385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Chemotherapy for Nasopharyngeal Cancer: Neoadjuvant, Concomitant, and\/or Adjuvant"],"prefix":"10.1007","volume":"16","author":[{"given":"Wai Tong","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy T. Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah W. M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry C. K.","family":"Sze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne W. M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,19]]},"reference":[{"key":"361_CR1","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","volume":"16","author":"M Al-Sarraf","year":"1998","unstructured":"Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 1998;16:1310\u20137.","journal-title":"J Clin Oncol"},{"key":"361_CR2","unstructured":"Al-Sarraf M, LeBlanc M, Giri PG, et al. Superiority of five year survival with chemoradiotherapy (CT-radiotherapy) vs radiotherapy in patients (Pts) with locally advanced nasopharyngeal cancer (NPC). Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) phase III study: final report. Proc Am Soc Clin Oncol. 20; Abstract 905."},{"key":"361_CR3","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1200\/JCO.2005.16.790","volume":"23","author":"J Wee","year":"2005","unstructured":"Wee J, Tan EH, Tai BC, et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer\/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol. 2005;23:6730\u20138.","journal-title":"J Clin Oncol"},{"key":"361_CR4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.47102\/annals-acadmedsg.V37N7p606","volume":"37","author":"J Wee","year":"2008","unstructured":"Wee J. 4th FY Khoo memorial lecture 2008: nasopharyngeal cancer workgroup\u2014the past, the present and the future. Ann Acad Med Singap. 2008;37:606\u201314.","journal-title":"Ann Acad Med Singap"},{"issue":"5","key":"361_CR5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ejca.2010.10.026","volume":"47","author":"AW Lee","year":"2011","unstructured":"Lee AW, Tung SY, Ngan RK, et al. Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials. Eur J Cancer. 2011;47(5):656\u201366.","journal-title":"Eur J Cancer"},{"issue":"6","key":"361_CR6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1470-2045(15)70126-9","volume":"16","author":"P Blanchard","year":"2015","unstructured":"Blanchard P, Lee A, Marguet S, Leclercq J, Ng WT, Ma J, et al. Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): an update on 19 trials and 4,806 patients. Lancet Oncol. 2015;16(6):645\u201355. This updated meta-analysis, with a median follow-up of 7.7\u00a0years, is the first analysis to demonstrate the treatment effect of concomitant with or without adjuvant chemotherapy as distinct groups.","journal-title":"Lancet Oncol"},{"key":"361_CR7","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/cncr.28049","volume":"119","author":"Y Chen","year":"2013","unstructured":"Chen Y, Sun Y, Liang SB, et al. Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China. Cancer. 2013;119:2230\u20138.","journal-title":"Cancer"},{"key":"361_CR8","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/annonc\/mdt163","volume":"24","author":"X Wu","year":"2013","unstructured":"Wu X, Huang PY, Peng PJ, et al. Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma. Ann Oncol. 2013;24:2131\u20136.","journal-title":"Ann Oncol"},{"key":"361_CR9","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/jnci\/dji084","volume":"97","author":"AT Chan","year":"2005","unstructured":"Chan AT, Leung SF, Ngan RK, et al. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst. 2005;97:536\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"361_CR10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1200\/JCO.2003.06.158","volume":"21","author":"JC Lin","year":"2003","unstructured":"Lin JC, Jan JS, Hsu CY, et al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol. 2003;21:631\u20137.","journal-title":"J Clin Oncol"},{"key":"361_CR11","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1200\/JCO.2004.05.173","volume":"22","author":"DL Kwong","year":"2004","unstructured":"Kwong DL, Sham JS, Au GK, et al. Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. J Clin Oncol. 2004;22:2643\u201353.","journal-title":"J Clin Oncol"},{"key":"361_CR12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","volume":"21","author":"DJ Adelstein","year":"2003","unstructured":"Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21:92\u20138.","journal-title":"J Clin Oncol"},{"key":"361_CR13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijrobp.2005.06.037","volume":"64","author":"B Baujat","year":"2006","unstructured":"Baujat B, Audry H, Bourhis J, et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys. 2006;64:47\u201356.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"361_CR14","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ijrobp.2007.12.028","volume":"71","author":"Y Chen","year":"2008","unstructured":"Chen Y, Liu MZ, Liang SB, et al. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china. Int J Radiat Oncol Biol Phys. 2008;71:1356\u201364. This prospective randomized trial demonstrated superior outcome for NPC patient treatment with concurrent chemotherapy and adjuvant chemotherapy compared with radiotherapy alone, with significant improved 2-year OS, failure-free rate, and distant failure-free survival.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"361_CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1470-2045(11)70320-5","volume":"13","author":"L Chen","year":"2012","unstructured":"Chen L, Hu CS, Chen XZ, et al. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2012;13:163\u201371.","journal-title":"Lancet Oncol"},{"key":"361_CR16","doi-asserted-by":"crossref","unstructured":"What is the best treatment in nasopharyngeal carcinoma? An individual patient data network meta-analysis. Radiother Oncol. 2015; 114 (suppl 1; abstr OC003).","DOI":"10.1016\/S0167-8140(15)34763-0"},{"key":"361_CR17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1470-2045(12)70102-X","volume":"13","author":"N Liu","year":"2012","unstructured":"Liu N, Chen NY, Cui RX, et al. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol. 2012;13:633\u201341.","journal-title":"Lancet Oncol"},{"key":"361_CR18","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1200\/JCO.2010.33.7741","volume":"29","author":"HY Wang","year":"2011","unstructured":"Wang HY, Sun BY, Zhu ZH, et al. Eight-signature classifier for prediction of nasopharyngeal [corrected] carcinoma survival. J Clin Oncol. 2011;29:4516\u201325.","journal-title":"J Clin Oncol"},{"key":"361_CR19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1200\/JCO.2008.18.1545","volume":"27","author":"EP Hui","year":"2009","unstructured":"Hui EP, Ma BB, Leung SF, et al. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. J Clin Oncol. 2009;27:242\u20139.","journal-title":"J Clin Oncol"},{"key":"361_CR20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/annonc\/mdr116","volume":"23","author":"G Fountzilas","year":"2012","unstructured":"Fountzilas G, Ciuleanu E, Bobos M, et al. Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation. Ann Oncol. 2012;23:427\u201335.","journal-title":"Ann Oncol"},{"key":"361_CR21","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ijrobp.2015.01.002","volume":"91","author":"T Tan","year":"2015","unstructured":"Tan T, Lim WT, Fong KW, et al. Concurrent chemo-radiation with or without induction gemcitabine, carboplatin, and paclitaxel: a randomized, phase 2\/3 trial in locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2015;91:952\u201360.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"361_CR22","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/cncr.29208","volume":"121","author":"AW Lee","year":"2015","unstructured":"Lee AW, Ngan RK, Tung SY, et al. Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma. Cancer. 2015;121:1328\u201338. This six-arm randomized phase 3 trial conducted by the Hong Kong Nasopharyngeal Cancer Study Group showed improvement of outcome using induction PX (cisplatin and capecitabine); adjusted comparison of induction PX versus induction or adjuvant PF demonstrated lower hazard ratio of death or progression and less toxicity.","journal-title":"Cancer"},{"key":"361_CR23","doi-asserted-by":"crossref","unstructured":"Daoud J, Aup\u00e9rin A, Tao YG, et al. A randomized trial of concomitant cisplatin-RT +\/\u2212 induction TPF in locally advanced nasopharyngeal carcinomas. Radiother Oncol. 2015;114 Supp. 1 Abstract OC-004.","DOI":"10.1016\/S0167-8140(15)34764-2"},{"key":"361_CR24","unstructured":"Sun Y, Chen NY, Zhang N, Hu GQ. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregional advanced nasopharyngeal carcinoma: preliminary results of a phase 3 multicentre randomized controlled trial. The Croucher Foundation Advanced Study Institute\u2013Advances in Nasopharyngeal Carcinoma Studies. 2014."},{"key":"361_CR25","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ijrobp.2006.02.016","volume":"65","author":"DT Chua","year":"2006","unstructured":"Chua DT, Ma J, Sham JS, et al. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: subgroup analysis of two phase III trials. Int J Radiat Oncol Biol Phys. 2006;65:1300\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"361_CR26","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/MLG.0b013e3181626cfe","volume":"118","author":"CH Song","year":"2008","unstructured":"Song CH, Wu HG, Heo DS, et al. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma. Laryngoscope. 2008;118:663\u201370.","journal-title":"Laryngoscope"},{"key":"361_CR27","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.2000.18.10.2040","volume":"18","author":"SH Cheng","year":"2000","unstructured":"Cheng SH, Tsai SY, Yen KL, et al. Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma. J Clin Oncol. 2000;18:2040\u20135.","journal-title":"J Clin Oncol"},{"key":"361_CR28","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/jnci\/djr432","volume":"103","author":"QY Chen","year":"2011","unstructured":"Chen QY, Wen YF, Guo L, et al. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial. J Natl Cancer Inst. 2011;103:1761\u201370. This randomized study demonstrates benefit of concurrent chemoradiation in stage II nasopharyngeal cancer patients, with significant improvement in 5-year OS, PFS, and distant metastasis-free survival.","journal-title":"J Natl Cancer Inst"},{"key":"361_CR29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.radonc.2011.12.022","volume":"104","author":"HH Loong","year":"2012","unstructured":"Loong HH, Ma BB, Leung SF, et al. Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma. Radiother Oncol. 2012;104:300\u20134.","journal-title":"Radiother Oncol"},{"key":"361_CR30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2014.02.003","volume":"110","author":"AW Lee","year":"2014","unstructured":"Lee AW, Ng WT, Chan LL, et al. Evolution of treatment for nasopharyngeal cancer\u2014success and setback in the intensity-modulated radiotherapy era. Radiother Oncol. 2014;110:377\u201384.","journal-title":"Radiother Oncol"},{"key":"361_CR31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijrobp.2010.09.011","volume":"82","author":"SF Su","year":"2012","unstructured":"Su SF, Han F, Zhao C, et al. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone. Int J Radiat Oncol Biol Phys. 2012;82:327\u201333.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"361_CR32","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ijrobp.2008.09.008","volume":"74","author":"WW Xiao","year":"2009","unstructured":"Xiao WW, Han F, Lu TX, et al. Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2009;74:1070\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"361_CR33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/cncr.11485","volume":"98","author":"DT Chua","year":"2003","unstructured":"Chua DT, Sham JS, Kwong DL, et al. Treatment outcome after radiotherapy alone for patients with stage I-II nasopharyngeal carcinoma. Cancer. 2003;98:74\u201380.","journal-title":"Cancer"},{"key":"361_CR34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.oraloncology.2013.06.003","volume":"50","author":"WT Ng","year":"2014","unstructured":"Ng WT, Yuen KT, Au KH, et al. Staging of nasopharyngeal carcinoma\u2014the past, the present and the future. Oral Oncol. 2014;50:549\u201354.","journal-title":"Oral Oncol"},{"key":"361_CR35","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/cncr.11496","volume":"98","author":"SF Leung","year":"2003","unstructured":"Leung SF, Chan AT, Zee B, et al. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type. Cancer. 2003;98:288\u201391.","journal-title":"Cancer"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-015-0361-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-015-0361-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-015-0361-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T05:20:22Z","timestamp":1691817622000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-015-0361-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,19]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["361"],"URL":"https:\/\/doi.org\/10.1007\/s11864-015-0361-5","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,19]]},"article-number":"44"}}